Receiving a diagnosis of HER2+ and ER+ breast cancer that has spread or cannot be surgically removed can feel overwhelming, but understanding the condition and your options can help you navigate this challenging journey.
Understanding HER2+ and ER+ Breast Cancer
HER2+ and ER+ breast cancer refers to a type of breast cancer that is positive for both the human epidermal growth factor receptor 2 (HER2) and estrogen receptors (ER).
These receptors play a role in the growth and spread of cancer cells. When cancer is HER2+ and ER+, it means that the cancer cells have receptors that respond to signals from HER2 and estrogen, promoting their growth.
You May Also Like
Signs that Cancer Has Spread
Detecting signs that cancer has spread beyond the breast tissue is crucial. Symptoms may include persistent cough, bone pain, unexplained weight loss, headaches, or neurological symptoms like confusion or seizures.
However, it’s important to note that these symptoms can be caused by other conditions, so consulting with your healthcare provider for proper evaluation is essential.
Navigating the Diagnosis
If your healthcare provider has confirmed that your HER2+ and ER+ breast cancer has spread or cannot be surgically removed, it’s crucial to work closely with your healthcare team to develop a comprehensive treatment plan.
You May Also Like
This plan may include a combination of treatments tailored to your specific situation.
Treatment Options
- Targeted Therapy: Targeted therapies target HER2-positive cancer cells, slowing or stopping their growth.
- Hormone Therapy: Hormone therapy blocks the effects of estrogen on cancer cells, reducing the risk of cancer recurrence.
- Chemotherapy: Chemotherapy may be used to kill cancer cells throughout the body, particularly if the cancer is aggressive or has spread to distant organs.
- Radiation Therapy: Radiation therapy may be used to target specific areas of cancer spread, such as bone metastases, to relieve pain and control the growth of cancer cells.
5 Reasons to Try a Clinical Trial for HER2+ and ER+
If you’re facing HER2-positive, ER-positive breast cancer that has spread or can’t be surgically removed, participating in a clinical trial could be a game-changer. Here’s why:
Let our Genentech Trial Nurse answer any of your trial and eligibility questions.
Call: (888) 662-6728 (Mon-Fri, 5am-5pm PT)
Chat or Email, click here
Exploring New Options
Clinical trials offer access to cutting-edge treatments that may not be available otherwise. This gives you the opportunity to try an experimental drug that could enhance your current treatment plan.
Personalized Care
By joining a trial, you become part of a research community focused on improving treatments for your specific type of breast cancer. This means you’ll receive personalized care and attention from a team of experts dedicated to your well-being.
Active Involvement in Your Treatment
Trials empower you to take an active role in your treatment journey. You’ll work closely with your healthcare team to monitor your progress, which can be empowering and motivating.
Potential Health Benefits
While there are no guarantees, participating in a trial could lead to improved health outcomes, offering you a better quality of life.
Contribution to Future Treatments
By participating in a trial, you’re contributing to the advancement of medical knowledge. Your experience and feedback could help shape future treatments for HER2-positive, ER-positive breast cancer, benefiting others in the future.
Remember, joining a clinical trial is a personal decision that should be made in consultation with your healthcare team. They can provide you with all the information you need to make an informed choice about your treatment options.
HER2+ and ER+ breast cancer that has spread or cannot be surgically removed presents unique challenges, but with the right support and treatment, you can live a fulfilling life. By staying informed, seeking support, and working closely with your healthcare team, you can navigate this journey with strength and resilience.
